| Literature DB >> 26821815 |
Jinjung Choi1,2, Carlo Selmi3,4, Patrick S C Leung1, Thomas P Kenny1, Tania Roskams5, M Eric Gershwin1.
Abstract
Chemokines represent a major mediator of innate immunity and play a key role in the selective recruitment of cells during localized inflammatory responses. Beyond critical extracellular mediators of leukocyte trafficking, chemokines and their cognate receptors are expressed by a variety of resident and infiltrating cells (monocytes, lymphocytes, NK cells, mast cells, and NKT cells). Chemokines represent ideal candidates for mechanistic studies (particularly in murine models) to better understand the pathogenesis of chronic inflammation and possibly become biomarkers of disease. Nonetheless, therapeutic approaches targeting chemokines have led to unsatisfactory results in rheumatoid arthritis, while biologics against pro-inflammatory cytokines are being used worldwide with success. In this comprehensive review we will discuss the evidence supporting the involvement of chemokines and their specific receptors in mediating the effector cell response, utilizing the autoimmune/primary biliary cholangitis setting as a paradigm.Entities:
Keywords: Innate immunity; autoimmune cholangitis; biologics; chemokine receptor; monoclonal antibody; tolerance breakdown
Mesh:
Substances:
Year: 2016 PMID: 26821815 PMCID: PMC4935758 DOI: 10.1586/1744666X.2016.1147956
Source DB: PubMed Journal: Expert Rev Clin Immunol ISSN: 1744-666X Impact factor: 4.473